BetterLife Pharma Inc. (BETRF)
Develops psychiatric drugs and immune-boosting treatments for depression, viral infections, and cervical disease.
$0.17+0.11%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+139.1%
The outlook
BETRF is trading near the upper portion of its 52-week range and above both its 50- and 200-day moving averages, suggesting positive short-term momentum. Analyst coverage appears thin for this micro-cap biotech. The stock's current positioning reflects strength relative to its recent trading history.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
$26.8M
52-wk high
$0.20
52-wk low
$0.03
50-day avg
$0.09
200-day avg
$0.06
Trailing P/E
—